ArticleOpen forum infectious diseases2025

Risk of Post-COVID-19 Conditions Among Adolescents and Adults Who Received Nirmatrelvir-Ritonavir for Acute COVID-19: A Retrospective Cohort Study.

Alexandra F Dalton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.